Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases

INTRODUCTION: Responses to COVID-19 vaccination in patients with chronic pulmonary diseases are poorly characterised. We aimed to describe humoral responses following two doses of BNT162b2 mRNA COVID-19 vaccine and identify risk factors for impaired responses. METHODS: Prospective cohort study inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Harboe, Zitta Barrella, Hamm, Sebastian Rask, Pérez-Alós, Laura, Sivapalan, Pradeesh, Priemé, Helene, Wilcke, Torgny, Kjeldgaard, Peter, Shaker, Saher, Svorre Jordan, Alexander, Møller, Dina Leth, Heftdal, Line Dam, Madsen, Johannes Roth, Bayarri-Olmos, Rafael, Hansen, Cecilie Bo, Pries-Heje, Mia Marie, Hasselbalch, Rasmus Bo, Fogh, Kamille, Armenteros, Jose Juan Almagro, Hilsted, Linda, Sørensen, Erik, Lindegaard, Birgitte, Browatzki, Andrea, Biering-Sørensen, Tor, Frikke-Schmidt, Ruth, Ostrowski, Sisse Rye, Iversen, Kasper Karmark, Bundgaard, Henning, Nielsen, Susanne Dam, Garred, Peter, Jensen, Jens-Ulrik Stæhr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Respiratory Infection
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260234/
https://www.ncbi.nlm.nih.gov/pubmed/35793836
http://dx.doi.org/10.1136/bmjresp-2022-001268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260234/
https://www.ncbi.nlm.nih.gov/pubmed/35793836
http://dx.doi.org/10.1136/bmjresp-2022-001268

Ejemplares similares